4.7 Review

Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 145, Issue -, Pages 18-39

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2018.06.018

Keywords

Antibiotic resistance; Animal models; Bacteriophage; Bacteriophage therapy; Biofilm; Clinical treatment

Ask authors/readers for more resources

Viruses of bacteria - known as bacteriophages or phages - have been used clinically as antibacterial agents for nearly 100 years. Often this phage therapy is of long-standing, persistent, or chronic bacterial infections, and this can be particularly so given prior but insufficiently effective infection treatment using standard antibiotics. Such infections, in turn, often have a biofilm component. Phages in modern medicine thus are envisaged to serve especially as anti-biofilm/anti-persistent infection agents. Here I review the English-language literature concerning in vivo experimental and clinical phage treatment of longer-lived bacterial infections. Overall, published data appears to be supportive of a relatively high potential for phages to cure infections which are long standing and which otherwise have resisted treatment with antibieiotics. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available